After the fasting, the uncomfortable cleanse and a drowsy ride home, it's a relief to have your colonoscopy screening behind ...

The American Cancer Society projected for 2025 that there would be over 154,000 new cases of colorectal cancer and 52,900 deaths.

In low-resource regions such as Nigeria, most people with colorectal cancer are diagnosed too late for curative treatment ...

Recursion Pharmaceuticals, Inc. upgraded to Buy on promising REC-4881 data, strong partnerships, and AI-driven drug discovery ...

Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks.

Cancer. That medical condition that anybody who is sick and goes to the hospital to see a doctor, will not want to hear the doctor pronounce that he or she has been diagnosed with it. Just hearing ...

Colon cancer is hitting long before the usual screening age. If you could ID who's at risk, you could screen early and save ...

“The research that’s needed most is the risk stratification research—who do we screen,” says Dr. Gabre. By getting to the ...

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median ...

Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare ...

SALT LAKE CITY, Dec. 08, 2025 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a clinical-stage TechBio company decoding biology to radically improve lives, today announced positive Phase 1b/2 data from ...